Literature DB >> 11175253

Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

S J Korsmeyer1, M C Wei, M Saito, S Weiler, K J Oh, P H Schlesinger.   

Abstract

We review data supporting a model in which activated tBID results in an allosteric activation of BAK, inducing its intramembranous oligomerization into a proposed pore for cytochrome c efflux. The BH3 domain of tBID is not required for targeting but remains on the mitochondrial surface where it is required to trigger BAK to release cytochrome c. tBID functions not as a pore-forming protein but as a membrane targeted and concentrated death ligand. tBID induces oligomerization of BAK, and both Bid and Bak knockout mice indicate the importance of this event in the release of cytochrome c. In parallel, the full pro-apoptotic member BAX, which is highly homologous to BAK, rapidly forms pores in liposomes that release intravesicular FITC-cytochrome c approximately 20A. A definable pore progressed from approximately 11A consisting of two BAX molecules to a approximately 22A pore comprised of four BAX molecules, which transported cytochrome c. Thus, an activation cascade of pro-apoptotic proteins from BID to BAK or BAX integrates the pathway from surface death receptors to the irreversible efflux of cytochrome c. Cell Death and Differentiation (2000) 7, 1166 - 1173

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175253     DOI: 10.1038/sj.cdd.4400783

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  270 in total

1.  tcBid promotes Ca(2+) signal propagation to the mitochondria: control of Ca(2+) permeation through the outer mitochondrial membrane.

Authors:  György Csordás; Muniswamy Madesh; Bruno Antonsson; György Hajnóczky
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

2.  Propagation of the apoptotic signal by mitochondrial waves.

Authors:  P Pacher; G Hajnóczky
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

3.  The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage.

Authors:  Katarina Wikström; Maria Juhas; Anita Sjölander
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

4.  Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis.

Authors:  Pinghui Feng; Junsoo Park; Bok-Soo Lee; Sun-Hwa Lee; Richard J Bram; Jae U Jung
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Confirmation by FRET in individual living cells of the absence of significant amyloid beta -mediated caspase 8 activation.

Authors:  Reiko Onuki; Akira Nagasaki; Hiroaki Kawasaki; Tadashi Baba; Taro Q P Uyeda; Kazunari Taira
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

6.  A multimeric model for murine anti-apoptotic protein Bcl-2 and structural insights for its regulation by post-translational modification.

Authors:  Venkatarajan S Mathura; Kizhake V Soman; Tushar K Varma; Werner Braun
Journal:  J Mol Model       Date:  2003-08-30       Impact factor: 1.810

7.  Biphasic translocation of Bax to mitochondria.

Authors:  Michela Capano; Martin Crompton
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

8.  Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein.

Authors:  Xavier Roucou; Sylvie Montessuit; Bruno Antonsson; Jean-Claude Martinou
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

9.  Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.

Authors:  Deepak Nijhawan; Min Fang; Elie Traer; Qing Zhong; Wenhua Gao; Fenghe Du; Xiaodong Wang
Journal:  Genes Dev       Date:  2003-06-03       Impact factor: 11.361

Review 10.  Regulation of apoptosis by Bcl-2 family proteins.

Authors:  Alexandrina Burlacu
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.